This paper is in the following e-collection/theme issue:

Cancer and Clinical Trials (46) Web-based and Mobile Health Interventions (4140) Cancer Survivorship (353) Mobile Apps for Cancer Care and Cancer Prevention and Screening (275) Patient-Reported Outcome Measures (PROMs) (380) Doctor-Patient Communication on Cancer, Prevention, and Screening (82) Innovations and Technology in Cancer Care (560)

Published on in Vol 11 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/65960, first published .
Comparison of Electronic Surveillance With Routine Monitoring for Patients With Lymphoma at High Risk of Relapse: Prospective Randomized Controlled Phase 3 Trial (Sentinel Lymphoma)

Comparison of Electronic Surveillance With Routine Monitoring for Patients With Lymphoma at High Risk of Relapse: Prospective Randomized Controlled Phase 3 Trial (Sentinel Lymphoma)

Comparison of Electronic Surveillance With Routine Monitoring for Patients With Lymphoma at High Risk of Relapse: Prospective Randomized Controlled Phase 3 Trial (Sentinel Lymphoma)

Authors of this article:

Katell Le Dû1 Author Orcid Image ;   Adrien Chauchet2 Author Orcid Image ;   Sophie Sadot-Lebouvier1 Author Orcid Image ;   Olivier Fitoussi3 Author Orcid Image ;   Bijou Fontanet4 Author Orcid Image ;   Arnaud Saint-Lezer5 Author Orcid Image ;   Frédéric Maloisel6 Author Orcid Image ;   Cédric Rossi7 Author Orcid Image ;   Sylvain Carras8 Author Orcid Image ;   Anne Parcelier9 Author Orcid Image ;   Magali Balavoine10 Author Orcid Image ;   Anne-Lise Septans10 Author Orcid Image
Article Authors Cited by (1) Tweetations Metrics

Journals

  1. Ma Y, Song J, Song C, Zhang X. Dynamic changes in serum IL-6, TNF-α, and β₂-microglobulin as early predictors of post-treatment relapse in lymphoma: a prospective cohort study. Frontiers in Medicine 2026;13 View